AnneKerneur

Associate

Paris + 33.1.56.59.39.39

Connect:

Share

Anne Kerneur's practice focuses on venture capital, private equity, M&A, and capital markets. For more than a decade she has represented technology, life sciences, and other growth enterprises, as well as the venture firms, private equity firms, and industrial investors that finance them, at every stage of development from entrepreneurial start-ups to listed companies.

Anne's experience includes: the financing rounds of Recommerce, Geolid, Bonitasoft, and Supersonic Imagine; the LBO of Companeo by Carlyle; the MBO of 10 percent of the share capital of Le Noble Age (listed on the main market in Paris) by Nobilise; the IPOs of Inside Secure and EOS Imaging; the rights issue by Stentys; the public offering of ORNANE (redeemable in shares bonds) by Le Noble Age; the sale of Maporama to Tibco International; the sale of Dibcom to Parrot; and the IPO of Criteo on Nasdaq.

Experience

  • TreeFrog Therapeutics raises €64 million in Series B financing roundJones Day represented TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, in connection with its €64 million Series B financing round led by Bpifrance Large Venture and joined by Leonard Green & Partners L.P., Bristol Myers Squibb, and XAnge.
  • Deutsche Bank and Société Générale underwrite €165 million SPAC IPO by DEE TechJones Day represented Deutsche Bank, as sole global coordinator and joint bookrunner, and Société Générale, as joint bookrunner, in connection with the €165 million initial public offering by DEE Tech, the first ever French SPAC in the tech sector, which will be listed on the Professional Segment of the regulated market of Euronext Paris.
  • IntegraGen’s shareholders sell majority interest to OncoDNA in tender offerJones Day advised IntegraGen, a biotechnology company developing molecular markers for central nervous system and metabolic diseases, in connection with the public tender offer of shares by OncoDNA, a private health technology and precision medicine company focused on oncology.
  • Hi Inov leads $3.8 million Series A financing round of Per AngustaJones Day advised Hi Inov as lead investor in connection with the $3.8 million Series A financing round of Per Angusta, a French company that designs and markets SaaS software for the performance of purchasing teams.
  • Sofinnova participates in $5.6 million Series A financing round of Protera BioJones Day advised Sofinnova Partners in connection with the $5.6 million Series A financing round of Protera Bio, an Al-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions.
  • Ring Capital, SEB Alliance, Amundi Finance et Solidarité, and Raise Impact participate in €13.5 million financing round of CastalieJones Day represented Ring Capital, SEB Alliance, Amundi Finance et Solidarité, and Raise Impact in connection with the €13.5 million round of financing of Castalie, a French company engaged in the development, manufacturing, and marketing of water fountains and water cooling.
  • SymBiosis participates in €18 million Series B financing round of MaaT PharmaJones Day advised SymBiosis LLC, as lead investor, in connection with the €18 million Series B round of financing of MaaT Pharma, a French clinical-stage company developing microbiome-based biotherapeutics.
  • Carrefour acquires Potager CityJones Day advised Carrefour Group in its acquisition of Potager City, a French distributor of online subscription-based boxes of extra-fresh and seasonal fruit and vegetables sourced via short distribution channels.
  • Alven Capital invests in CardiologsJones Day represented Alven Capital SA in connection with its investment in Cardiologs, a company engaged in the development of an AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities.
  • Novo Holdings REPAIR Impact Fund invests €7 million in MutabilisJones Day advised Novo Holdings REPAIR Impact Fund in connection with the €7 million convertible financing of Mutabilis, a French company engaged in the development of novel antibacterials against Gram-negative infections.
  • Serena Capital invests €4.7 million in AccentaJones Day represented Serena Capital in connection with its €4.7 million investment in Accenta, a specialist in next-generation heating and heating technologies, low-carbon air conditioning for buildings and eco-neighborhoods.
  • Ring participates in €10 million financing round of SplioJones Day represented Ring Capital in connection with the €10 million financing round of Splio, a leading SaaS loyalty marketing platform, used by over 500 brands in eight different industries.
  • Hi Inov and Cipio Partners participate in €16.5 million financing round of AgorapulseJones Day represented Hi Inov Dentressangle and Cipio Partners in connection with the €16.5 million round of financing of Agorapulse, a French software editor which helps companies to manage their social media profiles, alongside Entrepreneur Venture.
  • Invus participates in €20 million investment in SensorionJones Day advised Invus, as lead investor, alongside with Sofinnova, in the €20 million (US$22.6 million) convertible bonds issue of Sensorion, a clinical-stage biopharmaceutical company, which specializes in the development of novel therapies to restore, treat, and prevent inner ear diseases.
  • Hi Inov and Demeter participate in €8 million Series B financing round of DeepkiJones Day advised Hi Inov and Demeter in connection with their €8 million (US$8.9 million) Series B financing round of Deepki, a software platform operating a Saas solution dedicated to monitoring utilities of its clients’ real estate assets and assisting them in monitoring their utility consumptions and potential economies.
  • Elaia Partners participates in €3.6 million Series A investment in PILIJones Day represented Elaia Partners in connection with its Series A investment in PILI, a French biotech company.
  • Implanet completes IPO on NYSE Euronext ParisJones Day represented Implanet SA, a medical technology company producing state-of-the-art implants used in orthopaedic surgery, in connection with the issuance of €14.1 million (US$19.4 million) of New Shares in an initial public offering on the NYSE Euronext Paris.
  • Alven Capital invests in We Are Cloud, Inc. d/b/a BIME AnalyticsJones Day represented Alven Capital SA in connection with its purchase of Series A Convertible Preferred Stock in a private placement by We Are Cloud, Inc. d/b/a BIME Analytics, an all-in-one solution to help businesses analyze and monitor their business data in the cloud.
  • Criteo completes IPO of American Depository Shares on NASDAQJones Day advised Criteo S.A., a France-based technology company specializing in performance display advertising, in connection with its issuance of $288 million of Ordinary Shares in an initial public offering in the form of American Depository Shares on NASDAQ.
  • Omnes Capital invests in ProdealcenterJones Day advised Omnes Capital S.A. in connection with its purchase of €1 million (US$1.4 million) of Series A Convertible Preferred Stock in a private placement by Prodealcenter (d/b/a Agri Bargain), a specialist in online distribution of agricultural spare parts.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.